Patient Empowerment Network is excited to announce the addition of three new members to our diverse and talented board of directors.
Asalia Goldberg is a passionate patient advocate. She works in healthcare management with Boston Consulting Group (BCG) and has quite a bit of experience working with Fortune 500 companies in the biopharmaceutical industry where she has helped launch innovative therapies for oncology, rare disease, and heart disease. She has served as associate director of the non-profit Lymphoma Research Foundation and has been involved with Red Cross and Save the Children. She believes passionately in health equity and eliminating the disparities in healthcare through advocacy for patient education and empowerment.
Alyssa Gutjahr is a cyber security expert and brings a great deal of digital knowledge to the board. She has worked as a software development consultant for IBM and was a product manager for CNBC Digital. Currently she is a program director at NBCUniversal where she manages cyber security programs for the company. She is also active in a community outreach program that connects professional women in her company with young women in the community, hoping to inspire interest in science, technology, engineering, and math (STEM) careers.
Ray Parisi brings a wide array of skills and experience to the board. During his career he has been a financial analyst, a journalist, and a communications manager. He led corporate marketing and communications teams for big-name corporations Freddie Mac and AstraZeneca, helping to navigate the companies through challenging situations that included federal investigations for Freddie Mac, and corporate restructuring for AstraZeneca. He has also served on boards for Ronald McDonald House of Delaware and the AstraZeneca Healthcare Foundation. Currently, he is president of RJP communications LLC, where he specializes in public affairs and client communications.
The PEN board is made up of entrepreneurial-minded professionals who have a desire to support our mission to provide patients and their care partners with the resources they need to ensure the best possible path during their cancer journey and beyond. “The broad-ranging experiences of our board members truly serve our mission at PEN. Our members provide invaluable expertise that not only furthers our programs for patients and care partners, but also serves to ensure that our organization operates on firm ground and with sound business practices,” says PEN Executive Director Andrea Conners. “The addition of new board members exponentially increases our opportunities for success, and we are delighted to welcome them to our team.”
More information about all ten members of the PEN board can be found here.